(Q40711132)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

B J Kroesen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

A ter Haar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

H Spakman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

P Willemse

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

D T Sleijfer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

N H Mulder

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

H H Berendsen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

P C Limburg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

T H The

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 November 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

400-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7902211%20AND%20SRC:MED&resulttype=core&format=json

Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model

28 October 2019

cites work

1 reference

12 December 2020

OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

1 reference

12 December 2020

Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes

1 reference

12 December 2020

Selective chromosomal damage and cytotoxicity of 125I-labeled monoclonal antibody 17-1a in human cancer cells

1 reference

12 December 2020

Two monoclonal anti-CD3 antibodies can induce different events in human T lymphocyte activation

1 reference

12 December 2020

T cell targeting in cancer therapy

1 reference

12 December 2020

Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells

1 reference

12 December 2020

Cytokine release by peripheral blood lymphocytes targeted with bispecific antibodies, and its role in blocking tumor growth

1 reference

12 December 2020

Lymphocyte interactions with endothelial cells

1 reference

12 December 2020

Human c-erbB-2 proto-oncogene product as a target for bispecific-antibody-directed adoptive tumor immunotherapy

1 reference

12 December 2020

Hybrid hybridomas and the production of bi-specific monoclonal antibodies

1 reference

12 December 2020

Production of hybrid hybridomas based on HAT(s)-neomycin(r) double mutants

1 reference

12 December 2020

Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells

1 reference

12 December 2020

Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera

1 reference

12 December 2020

Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies

1 reference

12 December 2020

Treatment of mice bearing BCL1 lymphoma with bispecific antibodies

1 reference

12 December 2020

In vitro migration of lymphocytes through collagen matrix: arrested locomotion in tumor-infiltrating lymphocytes

1 reference

12 December 2020

Hybrid antibodies can target sites for attack by T cells

1 reference

12 December 2020

The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition

1 reference

12 December 2020

Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUAI

1 reference

12 December 2020

Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity

1 reference

12 December 2020

Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes

1 reference

12 December 2020

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

12 December 2020

Soluble CD8 during T cell activation

1 reference

12 December 2020

Specific lysis of human tumor cells by T cells coated with anti-T3 cross-linked to anti-tumor antibody

1 reference

12 December 2020

Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses

1 reference

12 December 2020

Preliminary trial of specific targeting therapy against malignant glioma

1 reference

12 December 2020

Heteroconjugate antibody-directed killing of autologous human renal carcinoma cells by in vitro-activated lymphocytes

1 reference

12 December 2020

Retargeting of human lymphocytes against human ovarian carcinoma cells by bispecific antibodies: from laboratory to clinic

1 reference

12 December 2020

Targeted cytotoxic cells in human peripheral blood lymphocytes

1 reference

12 December 2020

Tissue-specific migration pathways by phenotypically distinct subpopulations of memory T cells.

1 reference

12 December 2020

Refocusing the immune system to react with human tumors by targeting human lymphocytes with bispecific antibodies.

1 reference

12 December 2020

Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma

1 reference

12 December 2020

Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?

1 reference

12 December 2020

Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype.

1 reference

12 December 2020

Induction of cytotoxicity in human T cells coated with anti-glioma x anti-CD3 bispecific antibody against human glioma cells

1 reference

12 December 2020

Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones

1 reference

12 December 2020

ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis

1 reference

12 December 2020